N-ACETYLASPARTATE DEFICIENCY
|
0.300 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia.
|
19807691 |
2009 |
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hernia, Inguinal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Stereotyped Behavior
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Stereotypic Movement Disorder
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Gait, Unsteady
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Reduced concentration span
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Short stature
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ataxia, Truncal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Global developmental delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Weight decreased
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Generalized hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Short Stature, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Psychotic Disorders
|
0.020 |
Biomarker
|
group |
BEFREE |
We previously identified Shati/Nat8l, an N-acetyltransferase, in the brain using an animal model of psychosis.
|
31520691 |
2019 |
Unipolar Depression
|
0.020 |
Biomarker
|
disease |
BEFREE |
In this study, we revealed the involvement of Shati/Nat8l in the vulnerability to major depression.
|
31520691 |
2019 |
Nonorganic psychosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
We previously identified Shati/Nat8l, an N-acetyltransferase, in the brain using an animal model of psychosis.
|
31520691 |
2019 |
Major Depressive Disorder
|
0.020 |
Biomarker
|
disease |
BEFREE |
In this study, we revealed the involvement of Shati/Nat8l in the vulnerability to major depression.
|
31520691 |
2019 |
Psychotic Disorders
|
0.020 |
Biomarker
|
group |
BEFREE |
We have previously identified Shati/Nat8l, an N-acetyltransferase, in the brain using an animal model of psychosis.
|
29020418 |
2017 |
Unipolar Depression
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Our findings indicate that the striatal expression of N-acetylaspartate synthetase Shati/Nat8l plays a role in major depressive disorder via the metabotropic glutamate receptor 3-mediated functional control of the serotonergic neuronal system.
|
29020418 |
2017 |
Nonorganic psychosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
We have previously identified Shati/Nat8l, an N-acetyltransferase, in the brain using an animal model of psychosis.
|
29020418 |
2017 |
Major Depressive Disorder
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Our findings indicate that the striatal expression of N-acetylaspartate synthetase Shati/Nat8l plays a role in major depressive disorder via the metabotropic glutamate receptor 3-mediated functional control of the serotonergic neuronal system.
|
29020418 |
2017 |
Mental Depression
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, Shati/Nat8l in the striatum has an important role in the vulnerability to depression onsets by regulating the origin of serotonergic neuronal system via GABAergic projection neuron in the dorsal raphe from the dorsal striatum.
|
31520691 |
2019 |
Depressive disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, Shati/Nat8l in the striatum has an important role in the vulnerability to depression onsets by regulating the origin of serotonergic neuronal system via GABAergic projection neuron in the dorsal raphe from the dorsal striatum.
|
31520691 |
2019 |